Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver Transplantation.

arterial calcification liver fibrosis pyrophosphate

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
24 Jun 2022
Historique:
received: 26 04 2022
revised: 11 06 2022
accepted: 14 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Liver fibrosis is associated with arterial calcification (AC). Since the liver is a source of inorganic pyrophosphate (PPi), an anti-calcifying compound, we investigated the relationship between plasma PPi ([PPi]pl), liver fibrosis, liver function, AC, and the hepatic expression of genes regulating PPi homeostasis. To that aim, we compared [PPi]pl before liver transplantation (LT) and 3 months after LT. We also assessed the expression of four key regulators of PPi in liver tissues and established correlations between AC, and scores of liver fibrosis and liver failure in these patients. LT candidates with various liver diseases were included. AC scores were assessed in coronary arteries, abdominal aorta, and aortic valves. Liver fibrosis was evaluated on liver biopsies and from non-invasive tests (FIB-4 and APRI scores). Liver functions were assessed by measuring serum albumin, ALBI, MELD, and Pugh−Child scores. An enzymatic assay was used to dose [PPi]pl. A group of patients without liver alterations from a previous cohort provided a control group. Gene expression assays were performed with mRNA extracted from liver biopsies and compared between LT recipients and the control individuals. [PPi]pl negatively correlated with APRI (r = −0.57, p = 0.001, n = 29) and FIB-4 (r = −0.47, p = 0.006, n = 29) but not with interstitial fibrosis index from liver biopsies (r = 0.07, p = 0.40, n = 16). Serum albumin positively correlated with [PPi]pl (r = 0.71; p < 0.0001, n = 20). ALBI, MELD, and Pugh−Child scores correlated negatively with [PPi]pl (r = −0.60, p = 0.0005; r = −0.56, p = 0.002; r = −0.41, p = 0.02, respectively, with n = 20). Liver fibrosis assessed on liver biopsies by FIB-4 and by APRI positively correlated with coronary AC (r = 0.51, p = 0.02, n = 16; r = 0.58, p = 0.009, n = 20; r = 0.41, p = 0.04, n = 20, respectively) and with abdominal aorta AC (r = 0.50, p = 0.02, n = 16; r = 0.67, p = 0.002, n = 20; r = 0.61, p = 0.04, n = 20, respectively). FIB-4 also positively correlated with aortic valve calcification (r = 0.40, p = 0.046, n = 20). The key regulator genes of PPi production in liver were lower in patients undergoing liver transplantation as compared to controls. Three months after surgery, serum albumin levels were restored to physiological levels (40 [37−44] vs. 35 [30−40], p = 0.009) and [PPi]pl was normalized (1.40 [1.07−1.86] vs. 0.68 [0.53−0.80] µmol/L, p = 0.0005, n = 12). Liver failure and/or fibrosis correlated with AC in several arterial beds and were associated with low plasma PPi and dysregulation of key proteins involved in PPi homeostasis. Liver transplantation normalized these parameters.

Identifiants

pubmed: 35884801
pii: biomedicines10071496
doi: 10.3390/biomedicines10071496
pmc: PMC9312703
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : P20GM113134
Pays : United States

Références

Diabetes Metab. 2016 Nov;42(5):364-367
pubmed: 27016890
Nephrol Dial Transplant. 2003 Sep;18(9):1731-40
pubmed: 12937218
Hepatology. 2013 Apr;57(4):1357-65
pubmed: 23175136
Cell Mol Biol Lett. 2014 Dec;19(4):517-26
pubmed: 25169437
Cell Cycle. 2015;14(7):1082-9
pubmed: 25607347
Dig Dis Sci. 2010 Jun;55(6):1752-60
pubmed: 19688595
Int J Cardiol. 2021 Sep 15;339:219-224
pubmed: 34181996
Nat Rev Endocrinol. 2017 Sep;13(9):509-520
pubmed: 28621339
Cardiovasc Res. 2018 Mar 15;114(4):590-600
pubmed: 29514202
Nat Genet. 2000 Jun;25(2):223-7
pubmed: 10835642
Nat Genet. 2000 Jun;25(2):228-31
pubmed: 10835643
J Am Soc Nephrol. 2005 Aug;16(8):2495-500
pubmed: 15958726
Front Cell Dev Biol. 2020 Dec 03;8:586831
pubmed: 33425894
Gut. 2010 Sep;59(9):1265-9
pubmed: 20801772
J Gastroenterol Hepatol. 2015 Oct;30(10):1536-42
pubmed: 25973647
Gastroenterology. 2006 Sep;131(3):788-96
pubmed: 16952548
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20206-11
pubmed: 24277820
Hepatol Res. 2016 Oct;46(11):1107-1117
pubmed: 26853695
Front Cardiovasc Med. 2019 Jan 18;5:196
pubmed: 30713844
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):298-304
pubmed: 25629574
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
N Engl J Med. 2018 Jun 07;378(23):2171-2181
pubmed: 29874528
Clin Gastroenterol Hepatol. 2012 Jun;10(6):646-50
pubmed: 22245962
Am J Pathol. 2017 Jun;187(6):1258-1272
pubmed: 28416300
EMBO Mol Med. 2017 Nov;9(11):1463-1470
pubmed: 28701330
J Am Heart Assoc. 2015 Dec 16;4(12):
pubmed: 26675253
Hepatology. 2015 Jun;61(6):2080-90
pubmed: 25603770
J Am Soc Nephrol. 2000 Apr;11(4):778-783
pubmed: 10752538
Am J Kidney Dis. 2004 Feb;43(2):313-9
pubmed: 14750097
J Invest Dermatol. 2017 May;137(5):1025-1032
pubmed: 28111129
J Hepatol. 2017 Aug;67(2):328-338
pubmed: 28323124
Mol Aspects Med. 2019 Feb;65:37-55
pubmed: 30213667
J Clin Oncol. 2015 Feb 20;33(6):550-8
pubmed: 25512453
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6001-6
pubmed: 10811882
J Invest Dermatol. 2017 Nov;137(11):2336-2343
pubmed: 28652107
Nephrol Dial Transplant. 2010 Jan;25(1):187-91
pubmed: 19633093
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1985-9
pubmed: 24969777
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
BMJ. 2011 Nov 18;343:d6891
pubmed: 22102439
Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31
pubmed: 16205470
Lancet. 2014 May 17;383(9930):1749-61
pubmed: 24480518
Am J Kidney Dis. 1996 Mar;27(3):394-401
pubmed: 8604709
Gut. 2019 Sep;68(9):1667-1675
pubmed: 30472683
Atherosclerosis. 2014 Sep;236(1):7-17
pubmed: 24998934
Int J Mol Sci. 2017 Sep 11;18(9):
pubmed: 28891970
Ann Transl Med. 2019 Dec;7(24):798
pubmed: 32042814
J Am Coll Cardiol. 2007 May 8;49(18):1860-70
pubmed: 17481445
J Intern Med. 2021 May;289(5):709-725
pubmed: 33107650
Eur J Biochem. 1993 Oct 1;217(1):421-8
pubmed: 8223581
Clin Chim Acta. 2015 Jan 1;438:401-14
pubmed: 25236333
Sci Rep. 2019 Dec 11;9(1):18788
pubmed: 31827139
Semin Liver Dis. 2008 Feb;28(1):110-22
pubmed: 18293281
Am J Gastroenterol. 2006 Aug;101(8):1824-33
pubmed: 16790033
Hepatology. 2006 Jun;43(6):1317-25
pubmed: 16729309
Histochem Cell Biol. 2005 Jun;123(4-5):517-28
pubmed: 15889270
Atherosclerosis. 1997 Jul 25;132(2):245-50
pubmed: 9242971
Gastroenterology. 2003 Jan;124(1):91-6
pubmed: 12512033

Auteurs

Audrey Laurain (A)

Department of Nephrology, Pasteur 1 University Hospital, 06001 Nice, France.
Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
LP2M CNRS UMR 7370, Tour Pasteur, 28 Avenue de Valombrose, 06000 Nice, France.

Isabelle Rubera (I)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
LP2M CNRS UMR 7370, Tour Pasteur, 28 Avenue de Valombrose, 06000 Nice, France.

Micheline Razzouk-Cadet (M)

Department of Nuclear Medicine, Archet 1 University Hospital, 06200 Nice, France.

Stéphanie Bonnafous (S)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
Team 8 "Chronic Liver Diseases Associated with Obesity and Alcohol" Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M) Bâtiment Universitaire ARCHIMED? 151 Route Saint Antoine de Ginestière BP 2 3194, 06204 Nice, France.
Digestive Unit, Archet 2 University Hospital, 06200 Nice, France.

Miguel Albuquerque (M)

Pathology Department, Beaujon University Hospital, AP-HP, 92110 Clichy, France.
Inserm U1149, Beaujon University Hospital, 92110 Clichy, France.

Valérie Paradis (V)

Pathology Department, Beaujon University Hospital, AP-HP, 92110 Clichy, France.
Inserm U1149, Beaujon University Hospital, 92110 Clichy, France.

Stéphanie Patouraux (S)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
Pathology Department, Pasteur 1 University Hospital, 06000 Nice, France.

Christophe Duranton (C)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
LP2M CNRS UMR 7370, Tour Pasteur, 28 Avenue de Valombrose, 06000 Nice, France.

Olivier Lesaux (O)

Department Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813-5534, USA.

Georges Lefthériotis (G)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
LP2M CNRS UMR 7370, Tour Pasteur, 28 Avenue de Valombrose, 06000 Nice, France.
Department of Vascular Medicine and Surgery, Pasteur 1 University Hospital, 06000 Nice, France.

Albert Tran (A)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
Team 8 "Chronic Liver Diseases Associated with Obesity and Alcohol" Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M) Bâtiment Universitaire ARCHIMED? 151 Route Saint Antoine de Ginestière BP 2 3194, 06204 Nice, France.
Digestive Unit, Archet 2 University Hospital, 06200 Nice, France.

Rodolphe Anty (R)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
Team 8 "Chronic Liver Diseases Associated with Obesity and Alcohol" Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M) Bâtiment Universitaire ARCHIMED? 151 Route Saint Antoine de Ginestière BP 2 3194, 06204 Nice, France.
Digestive Unit, Archet 2 University Hospital, 06200 Nice, France.

Philippe Gual (P)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
Team 8 "Chronic Liver Diseases Associated with Obesity and Alcohol" Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M) Bâtiment Universitaire ARCHIMED? 151 Route Saint Antoine de Ginestière BP 2 3194, 06204 Nice, France.

Antonio Iannelli (A)

Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
Team 8 "Chronic Liver Diseases Associated with Obesity and Alcohol" Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M) Bâtiment Universitaire ARCHIMED? 151 Route Saint Antoine de Ginestière BP 2 3194, 06204 Nice, France.
Digestive Unit, Archet 2 University Hospital, 06200 Nice, France.

Guillaume Favre (G)

Department of Nephrology, Pasteur 1 University Hospital, 06001 Nice, France.
Faculty of Medicine, Tour Pasteur, 28 Avenue de Valombrose, University of Côte d'Azur, 06000 Nice, France.
LP2M CNRS UMR 7370, Tour Pasteur, 28 Avenue de Valombrose, 06000 Nice, France.

Classifications MeSH